| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $0 ) |
| | 2024 | 2020 | SYNERGYAN LLC | 1228 W EDGEWATER DR | GILBERT | AZ | 85233-7041 | MARICOPA | USA | R41TR003247 | DEVELOPMENT OF NOVEL AMINOGLYCOSIDE POLYMERS AND NANOPARTICLES FOR NUCLEIC ACID DELIVERY IN CHRONIC WOUNDS | 000 | 1 | NIH | 3/1/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2020 | SYNERGYAN LLC | 1228 W EDGEWATER DR | GILBERT | AZ | 85233-7041 | MARICOPA | USA | R41TR003247 | DEVELOPMENT OF NOVEL AMINOGLYCOSIDE POLYMERS AND NANOPARTICLES FOR NUCLEIC ACID DELIVERY IN CHRONIC WOUNDS | 000 | 1 | NIH | 11/2/2022 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $324,999 ) |
| | 2020 | 2020 | SYNERGYAN, LLC | 1228 W EDGE WATER DR | GILBERT | AZ | 85233-7041 | MARICOPA | USA | R41TR003247 | DEVELOPMENT OF NOVEL AMINOGLYCOSIDE POLYMERS AND NANOPARTICLES FOR NUCLEIC ACID DELIVERY IN CHRONIC WOUNDS | 001 | 1 | NIH | 8/26/2020 | $0 |
| | 2020 | 2020 | SYNERGYAN, LLC | 1228 W EDGE WATER DR | GILBERT | AZ | 85233-7041 | MARICOPA | USA | R41TR003247 | DEVELOPMENT OF NOVEL AMINOGLYCOSIDE POLYMERS AND NANOPARTICLES FOR NUCLEIC ACID DELIVERY IN CHRONIC WOUNDS | 000 | 1 | NIH | 7/10/2020 | $324,999 |
|
|
